The global Precision Cancer Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Therapeutics include AbbVie, Astellas Pharma U.S., Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Clovis Oncology, Inc., Dendreon Pharmaceuticals LLC, Eli Lilly & Company and EMD Serono, Inc. (Merck KgaA), etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapeutics. This report contains market size and forecasts of Precision Cancer Therapeutics in global, including the following market information:
Global Precision Cancer Therapeutics Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Precision Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Therapeutics Market, by Type, 2020-2024, 2025-2030 ($ millions)
Global Precision Cancer Therapeutics Market Segment Percentages, by Type, 2023 (%)
Monoclonal Antibodies
Kinase Inhibitors
Angiogenesis Inhibitors
Proteasome Inhibitors
CAR-T Therapies
Other Precision Therapies
Global Precision Cancer Therapeutics Market, by Application, 2020-2024, 2025-2030 ($ millions)
Global Precision Cancer Therapeutics Market Segment Percentages, by Application, 2023 (%)
Breast Cancer
Lung Cancer
Prostate Cancer
Colon and Rectal Cancer
Others
Global Precision Cancer Therapeutics Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions)
Global Precision Cancer Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Therapeutics revenues in global market, 2020-2024 (estimated), ($ millions)
Key companies Precision Cancer Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma U.S., Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Clovis Oncology, Inc.
Dendreon Pharmaceuticals LLC
Eli Lilly & Company
EMD Serono, Inc. (Merck KgaA)
Eisai Co., Ltd.
Exelixis, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Otsuka Holdings Co., Ltd.
Pfizer, Inc.
Puma Biotechnology, Inc.
Roche (F. Hoffman-La Roche, Ltd.)
Sanofi/Genzyme
Seagen Inc.
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Therapeutics, market overview.
Chapter 2: Global Precision Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Therapeutics Overall Market Size
2.1 Global Precision Cancer Therapeutics Market Size: 2023 VS 2030
2.2 Global Precision Cancer Therapeutics Market Size, Prospects & Forecasts: 2020-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Therapeutics Players in Global Market
3.2 Top Global Precision Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Precision Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Precision Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precision Cancer Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Kinase Inhibitors
4.1.4 Angiogenesis Inhibitors
4.1.5 Proteasome Inhibitors
4.1.6 CAR-T Therapies
4.1.7 Other Precision Therapies
4.2 By Type - Global Precision Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Therapeutics Revenue, 2020-2024
4.2.2 By Type - Global Precision Cancer Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Therapeutics Market Size, 2023 & 2030
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Prostate Cancer
5.1.5 Colon and Rectal Cancer
5.1.6 Others
5.2 By Application - Global Precision Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Therapeutics Revenue, 2020-2024
5.2.2 By Application - Global Precision Cancer Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
6 Sights by Region
6.1 By Region - Global Precision Cancer Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Precision Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Therapeutics Revenue, 2020-2024
6.2.2 By Region - Global Precision Cancer Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
6.3 North America
6.3.1 By Country - North America Precision Cancer Therapeutics Revenue, 2020-2030
6.3.2 US Precision Cancer Therapeutics Market Size, 2020-2030
6.3.3 Canada Precision Cancer Therapeutics Market Size, 2020-2030
6.3.4 Mexico Precision Cancer Therapeutics Market Size, 2020-2030
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Therapeutics Revenue, 2020-2030
6.4.2 Germany Precision Cancer Therapeutics Market Size, 2020-2030
6.4.3 France Precision Cancer Therapeutics Market Size, 2020-2030
6.4.4 U.K. Precision Cancer Therapeutics Market Size, 2020-2030
6.4.5 Italy Precision Cancer Therapeutics Market Size, 2020-2030
6.4.6 Russia Precision Cancer Therapeutics Market Size, 2020-2030
6.4.7 Nordic Countries Precision Cancer Therapeutics Market Size, 2020-2030
6.4.8 Benelux Precision Cancer Therapeutics Market Size, 2020-2030
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Therapeutics Revenue, 2020-2030
6.5.2 China Precision Cancer Therapeutics Market Size, 2020-2030
6.5.3 Japan Precision Cancer Therapeutics Market Size, 2020-2030
6.5.4 South Korea Precision Cancer Therapeutics Market Size, 2020-2030
6.5.5 Southeast Asia Precision Cancer Therapeutics Market Size, 2020-2030
6.5.6 India Precision Cancer Therapeutics Market Size, 2020-2030
6.6 South America
6.6.1 By Country - South America Precision Cancer Therapeutics Revenue, 2020-2030
6.6.2 Brazil Precision Cancer Therapeutics Market Size, 2020-2030
6.6.3 Argentina Precision Cancer Therapeutics Market Size, 2020-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Therapeutics Revenue, 2020-2030
6.7.2 Turkey Precision Cancer Therapeutics Market Size, 2020-2030
6.7.3 Israel Precision Cancer Therapeutics Market Size, 2020-2030
6.7.4 Saudi Arabia Precision Cancer Therapeutics Market Size, 2020-2030
6.7.5 UAE Precision Cancer Therapeutics Market Size, 2020-2030
7 Precision Cancer Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Precision Cancer Therapeutics Major Product Offerings
7.1.4 AbbVie Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma U.S., Inc
7.2.1 Astellas Pharma U.S., Inc Company Summary
7.2.2 Astellas Pharma U.S., Inc Business Overview
7.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Major Product Offerings
7.2.4 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.2.5 Astellas Pharma U.S., Inc Key News & Latest Developments
7.3 AstraZeneca PLC
7.3.1 AstraZeneca PLC Company Summary
7.3.2 AstraZeneca PLC Business Overview
7.3.3 AstraZeneca PLC Precision Cancer Therapeutics Major Product Offerings
7.3.4 AstraZeneca PLC Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.3.5 AstraZeneca PLC Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Precision Cancer Therapeutics Major Product Offerings
7.4.4 Bayer AG Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Company Summary
7.5.2 Bristol-Myers Squibb Company Business Overview
7.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.5.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.6 Clovis Oncology, Inc.
7.6.1 Clovis Oncology, Inc. Company Summary
7.6.2 Clovis Oncology, Inc. Business Overview
7.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Major Product Offerings
7.6.4 Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.6.5 Clovis Oncology, Inc. Key News & Latest Developments
7.7 Dendreon Pharmaceuticals LLC
7.7.1 Dendreon Pharmaceuticals LLC Company Summary
7.7.2 Dendreon Pharmaceuticals LLC Business Overview
7.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Major Product Offerings
7.7.4 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.7.5 Dendreon Pharmaceuticals LLC Key News & Latest Developments
7.8 Eli Lilly & Company
7.8.1 Eli Lilly & Company Company Summary
7.8.2 Eli Lilly & Company Business Overview
7.8.3 Eli Lilly & Company Precision Cancer Therapeutics Major Product Offerings
7.8.4 Eli Lilly & Company Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.8.5 Eli Lilly & Company Key News & Latest Developments
7.9 EMD Serono, Inc. (Merck KgaA)
7.9.1 EMD Serono, Inc. (Merck KgaA) Company Summary
7.9.2 EMD Serono, Inc. (Merck KgaA) Business Overview
7.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Major Product Offerings
7.9.4 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.9.5 EMD Serono, Inc. (Merck KgaA) Key News & Latest Developments
7.10 Eisai Co., Ltd.
7.10.1 Eisai Co., Ltd. Company Summary
7.10.2 Eisai Co., Ltd. Business Overview
7.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Major Product Offerings
7.10.4 Eisai Co., Ltd. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.10.5 Eisai Co., Ltd. Key News & Latest Developments
7.11 Exelixis, Inc.
7.11.1 Exelixis, Inc. Company Summary
7.11.2 Exelixis, Inc. Business Overview
7.11.3 Exelixis, Inc. Precision Cancer Therapeutics Major Product Offerings
7.11.4 Exelixis, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.11.5 Exelixis, Inc. Key News & Latest Developments
7.12 Gilead Sciences, Inc.
7.12.1 Gilead Sciences, Inc. Company Summary
7.12.2 Gilead Sciences, Inc. Business Overview
7.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Major Product Offerings
7.12.4 Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.12.5 Gilead Sciences, Inc. Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Precision Cancer Therapeutics Major Product Offerings
7.13.4 GlaxoSmithKline Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.13.5 GlaxoSmithKline Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Precision Cancer Therapeutics Major Product Offerings
7.14.4 Johnson & Johnson Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Merck & Co., Inc.
7.15.1 Merck & Co., Inc. Company Summary
7.15.2 Merck & Co., Inc. Business Overview
7.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Major Product Offerings
7.15.4 Merck & Co., Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.15.5 Merck & Co., Inc. Key News & Latest Developments
7.16 Novartis AG
7.16.1 Novartis AG Company Summary
7.16.2 Novartis AG Business Overview
7.16.3 Novartis AG Precision Cancer Therapeutics Major Product Offerings
7.16.4 Novartis AG Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.16.5 Novartis AG Key News & Latest Developments
7.17 Otsuka Holdings Co., Ltd.
7.17.1 Otsuka Holdings Co., Ltd. Company Summary
7.17.2 Otsuka Holdings Co., Ltd. Business Overview
7.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Major Product Offerings
7.17.4 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.17.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
7.18 Pfizer, Inc.
7.18.1 Pfizer, Inc. Company Summary
7.18.2 Pfizer, Inc. Business Overview
7.18.3 Pfizer, Inc. Precision Cancer Therapeutics Major Product Offerings
7.18.4 Pfizer, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.18.5 Pfizer, Inc. Key News & Latest Developments
7.19 Puma Biotechnology, Inc.
7.19.1 Puma Biotechnology, Inc. Company Summary
7.19.2 Puma Biotechnology, Inc. Business Overview
7.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Major Product Offerings
7.19.4 Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.19.5 Puma Biotechnology, Inc. Key News & Latest Developments
7.20 Roche (F. Hoffman-La Roche, Ltd.)
7.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Summary
7.20.2 Roche (F. Hoffman-La Roche, Ltd.) Business Overview
7.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Major Product Offerings
7.20.4 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.20.5 Roche (F. Hoffman-La Roche, Ltd.) Key News & Latest Developments
7.21 Sanofi/Genzyme
7.21.1 Sanofi/Genzyme Company Summary
7.21.2 Sanofi/Genzyme Business Overview
7.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Major Product Offerings
7.21.4 Sanofi/Genzyme Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.21.5 Sanofi/Genzyme Key News & Latest Developments
7.22 Seagen Inc.
7.22.1 Seagen Inc. Company Summary
7.22.2 Seagen Inc. Business Overview
7.22.3 Seagen Inc. Precision Cancer Therapeutics Major Product Offerings
7.22.4 Seagen Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.22.5 Seagen Inc. Key News & Latest Developments
7.23 Takeda
7.23.1 Takeda Company Summary
7.23.2 Takeda Business Overview
7.23.3 Takeda Precision Cancer Therapeutics Major Product Offerings
7.23.4 Takeda Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.23.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Therapeutics Market Drivers in Global Market
Table 3. Precision Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Therapeutics in Global Market
Table 5. Top Precision Cancer Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Precision Cancer Therapeutics Revenue by Companies, (US$, Mn), 2020-2024
Table 7. Global Precision Cancer Therapeutics Revenue Share by Companies, 2020-2024
Table 8. Global Companies Precision Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Precision Cancer Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Precision Cancer Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Precision Cancer Therapeutics Revenue in Global (US$, Mn), 2020-2024
Table 13. By Type - Precision Cancer Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Precision Cancer Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Precision Cancer Therapeutics Revenue in Global (US$, Mn), 2020-2024
Table 16. By Application - Precision Cancer Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Precision Cancer Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Precision Cancer Therapeutics Revenue (US$, Mn), 2020-2024
Table 19. By Region - Global Precision Cancer Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2024
Table 21. By Country - North America Precision Cancer Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2024
Table 23. By Country - Europe Precision Cancer Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2024
Table 25. By Region - Asia Precision Cancer Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2024
Table 27. By Country - South America Precision Cancer Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2024
Table 29. By Country - Middle East & Africa Precision Cancer Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Precision Cancer Therapeutics Product Offerings
Table 32. AbbVie Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. Astellas Pharma U.S., Inc Company Summary
Table 35. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product Offerings
Table 36. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 37. Astellas Pharma U.S., Inc Key News & Latest Developments
Table 38. AstraZeneca PLC Company Summary
Table 39. AstraZeneca PLC Precision Cancer Therapeutics Product Offerings
Table 40. AstraZeneca PLC Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 41. AstraZeneca PLC Key News & Latest Developments
Table 42. Bayer AG Company Summary
Table 43. Bayer AG Precision Cancer Therapeutics Product Offerings
Table 44. Bayer AG Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 45. Bayer AG Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Company Summary
Table 47. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product Offerings
Table 48. Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 49. Bristol-Myers Squibb Company Key News & Latest Developments
Table 50. Clovis Oncology, Inc. Company Summary
Table 51. Clovis Oncology, Inc. Precision Cancer Therapeutics Product Offerings
Table 52. Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 53. Clovis Oncology, Inc. Key News & Latest Developments
Table 54. Dendreon Pharmaceuticals LLC Company Summary
Table 55. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product Offerings
Table 56. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 57. Dendreon Pharmaceuticals LLC Key News & Latest Developments
Table 58. Eli Lilly & Company Company Summary
Table 59. Eli Lilly & Company Precision Cancer Therapeutics Product Offerings
Table 60. Eli Lilly & Company Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 61. Eli Lilly & Company Key News & Latest Developments
Table 62. EMD Serono, Inc. (Merck KgaA) Company Summary
Table 63. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product Offerings
Table 64. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 65. EMD Serono, Inc. (Merck KgaA) Key News & Latest Developments
Table 66. Eisai Co., Ltd. Company Summary
Table 67. Eisai Co., Ltd. Precision Cancer Therapeutics Product Offerings
Table 68. Eisai Co., Ltd. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 69. Eisai Co., Ltd. Key News & Latest Developments
Table 70. Exelixis, Inc. Company Summary
Table 71. Exelixis, Inc. Precision Cancer Therapeutics Product Offerings
Table 72. Exelixis, Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 73. Exelixis, Inc. Key News & Latest Developments
Table 74. Gilead Sciences, Inc. Company Summary
Table 75. Gilead Sciences, Inc. Precision Cancer Therapeutics Product Offerings
Table 76. Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 77. Gilead Sciences, Inc. Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Precision Cancer Therapeutics Product Offerings
Table 80. GlaxoSmithKline Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Precision Cancer Therapeutics Product Offerings
Table 84. Johnson & Johnson Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. Merck & Co., Inc. Company Summary
Table 87. Merck & Co., Inc. Precision Cancer Therapeutics Product Offerings
Table 88. Merck & Co., Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 89. Merck & Co., Inc. Key News & Latest Developments
Table 90. Novartis AG Company Summary
Table 91. Novartis AG Precision Cancer Therapeutics Product Offerings
Table 92. Novartis AG Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 93. Novartis AG Key News & Latest Developments
Table 94. Otsuka Holdings Co., Ltd. Company Summary
Table 95. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product Offerings
Table 96. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 97. Otsuka Holdings Co., Ltd. Key News & Latest Developments
Table 98. Pfizer, Inc. Company Summary
Table 99. Pfizer, Inc. Precision Cancer Therapeutics Product Offerings
Table 100. Pfizer, Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 101. Pfizer, Inc. Key News & Latest Developments
Table 102. Puma Biotechnology, Inc. Company Summary
Table 103. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product Offerings
Table 104. Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 105. Puma Biotechnology, Inc. Key News & Latest Developments
Table 106. Roche (F. Hoffman-La Roche, Ltd.) Company Summary
Table 107. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product Offerings
Table 108. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 109. Roche (F. Hoffman-La Roche, Ltd.) Key News & Latest Developments
Table 110. Sanofi/Genzyme Company Summary
Table 111. Sanofi/Genzyme Precision Cancer Therapeutics Product Offerings
Table 112. Sanofi/Genzyme Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 113. Sanofi/Genzyme Key News & Latest Developments
Table 114. Seagen Inc. Company Summary
Table 115. Seagen Inc. Precision Cancer Therapeutics Product Offerings
Table 116. Seagen Inc. Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 117. Seagen Inc. Key News & Latest Developments
Table 118. Takeda Company Summary
Table 119. Takeda Precision Cancer Therapeutics Product Offerings
Table 120. Takeda Precision Cancer Therapeutics Revenue (US$, Mn) & (2020-2024)
Table 121. Takeda Key News & Latest Developments
List of Figures
Figure 1. Precision Cancer Therapeutics Segment by Type in 2023
Figure 2. Precision Cancer Therapeutics Segment by Application in 2023
Figure 3. Global Precision Cancer Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Precision Cancer Therapeutics Revenue, 2020-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Therapeutics Revenue in 2023
Figure 8. By Type - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 9. By Application - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 10. By Type - Global Precision Cancer Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 12. By Application - Global Precision Cancer Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 14. By Region - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 15. By Country - North America Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 16. US Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 17. Canada Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 18. Mexico Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 19. By Country - Europe Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 20. Germany Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 21. France Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 22. U.K. Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 23. Italy Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 24. Russia Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 25. Nordic Countries Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 26. Benelux Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 27. By Region - Asia Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 28. China Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 29. Japan Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 30. South Korea Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 31. Southeast Asia Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 32. India Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 33. By Country - South America Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 34. Brazil Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 35. Argentina Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 36. By Country - Middle East & Africa Precision Cancer Therapeutics Revenue Market Share, 2020-2030
Figure 37. Turkey Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 38. Israel Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 39. Saudi Arabia Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 40. UAE Precision Cancer Therapeutics Revenue, (US$, Mn), 2020-2030
Figure 41. AbbVie Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 42. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 43. AstraZeneca PLC Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 44. Bayer AG Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 45. Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 46. Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 47. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 48. Eli Lilly & Company Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 49. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 50. Eisai Co., Ltd. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 51. Exelixis, Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 52. Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 53. GlaxoSmithKline Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 54. Johnson & Johnson Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 55. Merck & Co., Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 56. Novartis AG Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 57. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 58. Pfizer, Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 59. Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 60. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 61. Sanofi/Genzyme Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 62. Seagen Inc. Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
Figure 63. Takeda Precision Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2024)
